Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

BACKGROUND: A randomised phase 2 trial of trimodality with or without induction chemotherapy (IC) in oesophageal cancer (EC) patients showed no advantage in overall survival (OS) or pathologic complete response rate. To identify subsets that might benefit from IC, a secondary analysis was done. METH...

詳細記述

保存先:
書誌詳細
出版年:Br J Cancer
主要な著者: Shimodaira, Yusuke, Slack, Rebecca S, Harada, Kazuto, Chen, Hsiang-Chun, Sagebiel, Tara, Bhutani, Manoop S, Lee, Jeffrey H, Weston, Brian, Elimova, Elena, Lin, Quan, Amlashi, Fatemeh G, Mizrak Kaya, Dilsa, Blum, Mariela A, Roth, Jack A, Swisher, Stephen G, Skinner, Heath D, Hofstetter, Wayne L, Rogers, Jane E, Mares, Jaennette, Thomas, Irene, Maru, Dipen M, Komaki, Ritsuko, Walsh, Garrett, Ajani, Jaffer A
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2018
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808035/
https://ncbi.nlm.nih.gov/pubmed/29235564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.423
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料